estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet [Estratest]
- RxCUI
- 209251
- RxNorm name
- estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet [Estratest]
- Display name
- ESTRATEST (Oral Pill)
- Full name
- estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet [Estratest]
- Term type
- SBD
- Status
- Active
- Strength
- 0.625-1.25 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-11-16 22:44:33
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| estrogens, esterified (USP) | 0.625 MG / 1 EACH | estrogens, esterified (USP) | estrogens, esterified (USP) |
| methyltestosterone | 1.25 MG / 1 EACH | methyltestosterone | methyltestosterone |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| estrogens, esterified (USP) | 214549 |
| methyltestosterone | 6904 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Estratest H.S. 0.625 MG / 1.25 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet [Estratest] | 1 | NAMES |
| RxNorm Synonym | Estratest H.S. 0.625 MG / 1.25 MG Oral Tablet | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 209251 | 1 | CODES |
| MMSL_CODE | BD3734 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 58657-403-01 | 58657-403 | ESTRATEST H.S. ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | Method Pharmaceuticals, LLC | |
| 58657-416-01 | 58657-416 | Estratest HS Esterified Estrogens and Methyltestosterone | Method Pharmaceuticals |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ESTRATEST H.S. | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | Method Pharmaceuticals, LLC | 1ab6a396-b384-7958-e063-6394a90abfdd | 2025-10-21 | Boxed warning, Warnings, Adverse reactions | 58657-403-01 58657-403 58657040301 209251 |
| Estratest HS | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | Method Pharmaceuticals | 30074e3d-aa36-50c4-e063-6294a90a4d5c | 2025-03-10 | Boxed warning, Warnings, Adverse reactions | 58657-416-01 58657-416 58657041601 209251 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1ab6a396-b384-7958-e063-6394a90abfdd | Estratest H.S. 0.625 MG / 1.25 MG Oral Tablet [PSN] · estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet [Estratest] [SBD] · Estratest H.S. 0.625 MG / 1.25 MG Oral Tablet [SY] | 3 | 2 | 20251021 | |
| 30074e3d-aa36-50c4-e063-6294a90a4d5c | Estratest H.S. 0.625 MG / 1.25 MG Oral Tablet [PSN] · estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet [Estratest] [SBD] · Estratest H.S. 0.625 MG / 1.25 MG Oral Tablet [SY] | 3 | 2 | ESTRATEST H.S. AND ESTRATEST F.S. Tablets | 20250310 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 1ab6a396-b384-7958-e063-6394a90abfdd | Method Pharmaceuticals, LLC | 20251021 | |
| 30074e3d-aa36-50c4-e063-6294a90a4d5c | ESTRATEST H.S. AND ESTRATEST F.S. Tablets | Method Pharmaceuticals | 20250310 |
| 1ab6a396-b384-7958-e063-6394a90abfdd | Method Pharmaceuticals, LLC | 20240615 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | G03BA | 3-oxoandrosten (4) derivatives | ATC1-4 | methyltestosterone | |
| ATC | G03EK | Androgens and female sex hormones in combination with other drugs | ATC1-4 | methyltestosterone | |
| FDASPL | D000731 | Androstanes | CHEM | has_chemical_structure | methyltestosterone |
| FDASPL | N0000175824 | Androgen | EPC | has_epc | methyltestosterone |
| FDASPL | N0000000146 | Androgen Receptor Agonists | MOA | has_moa | methyltestosterone |
| MEDRT | D042724 | Estrogens, Esterified (USP) | CHEM | has_ingredient | estrogens, esterified (USP) |
| MEDRT | D008777 | Methyltestosterone | CHEM | has_ingredient | methyltestosterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | estrogens, esterified (USP) |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | methyltestosterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | estrogens, esterified (USP) |
| MEDRT | D018567 | Breast Neoplasms, Male | DISEASE | ci_with | methyltestosterone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | estrogens, esterified (USP) |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methyltestosterone |
| MEDRT | D007172 | Erectile Dysfunction | DISEASE | may_treat | methyltestosterone |
| MEDRT | D019584 | Hot Flashes | DISEASE | may_treat | estrogens, esterified (USP) |
| MEDRT | D007006 | Hypogonadism | DISEASE | may_treat | methyltestosterone |
| MEDRT | D007006 | Hypogonadism | DISEASE | may_treat | estrogens, esterified (USP) |
| MEDRT | D008594 | Menopause, Premature | DISEASE | may_treat | estrogens, esterified (USP) |
| MEDRT | D008595 | Menorrhagia | DISEASE | may_treat | estrogens, esterified (USP) |
| MEDRT | D009376 | Neoplasms, Hormone-Dependent | DISEASE | ci_with | estrogens, esterified (USP) |
| MEDRT | D015663 | Osteoporosis, Postmenopausal | DISEASE | may_prevent | estrogens, esterified (USP) |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | estrogens, esterified (USP) |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | methyltestosterone |
| MEDRT | D016649 | Primary Ovarian Insufficiency | DISEASE | may_treat | estrogens, esterified (USP) |
| MEDRT | D011471 | Prostatic Neoplasms | DISEASE | ci_with | methyltestosterone |
| MEDRT | D011471 | Prostatic Neoplasms | DISEASE | may_treat | estrogens, esterified (USP) |
| MEDRT | D011628 | Puberty, Delayed | DISEASE | may_treat | methyltestosterone |
| MEDRT | D013923 | Thromboembolism | DISEASE | ci_with | estrogens, esterified (USP) |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | estrogens, esterified (USP) |
| MEDRT | N0000000146 | Androgen Receptor Agonists | MOA | has_moa | methyltestosterone |
| MEDRT | N0000000100 | Estrogen Receptor Agonists | MOA | has_moa | estrogens, esterified (USP) |
| MEDRT | N0000008311 | Bone Formation Stimulation | PE | has_pe | estrogens, esterified (USP) |
| MEDRT | N0000009805 | Pituitary Gland Activity Alteration | PE | has_pe | estrogens, esterified (USP) |
| MEDRT | N0000009864 | Stimulate Penile Development | PE | has_pe | methyltestosterone |
| MEDRT | N0000009902 | Vaginal Function Alteration | PE | has_pe | estrogens, esterified (USP) |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | ACTIVATED | 06/25/2024 |
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.625 MG / 1.25 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 3 |
| NAMES | Prescribable Synonym | Estratest H.S. 0.625 MG / 1.25 MG Oral Tablet |
| NAMES | Tallman Synonym | estrogens, esterified (USP) 0.625 MG / methylTESTOSTERone 1.25 MG Oral Tablet [Estratest] |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |